Scripps News January 1, 2024
Americans are projected to spend $4 trillion on personal health care in 2024 — so what exactly will that entail?
Medical innovation is blooming in 2024, and it has the potential to positively impact many patients.
The end of 2023 brought the first FDA treatment using groundbreaking CRISPR gene editing technology to treat sickle cell patients. In 2024, the FDA is considering a similar treatment for another blood condition called beta thalassemia.
“Now there’s all sorts of new technologies where we could make all sorts of new changes to the DNA,” said Dr. Daniel Bauer, principal investigator at Boston Children’s Cancer and Blood Disorders Center.
There’s also anticipation for the results of a clinical trial in which gene editing is...
Today's Sponsors
Today's Sponsor